Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. More Details
Excellent balance sheet with acceptable track record.
Share Price & News
How has Pfizer's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PFIZER is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: PFIZER's weekly volatility (3%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: PFIZER exceeded the Indian Pharmaceuticals industry which returned 30.4% over the past year.
Return vs Market: PFIZER underperformed the Indian Market which returned 56.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Pfizer's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StShareholders Of Pfizer (NSE:PFIZER) Must Be Happy With Their 218% Total Return
4 months ago | Simply Wall StAre Institutions Heavily Invested In Pfizer Limited's (NSE:PFIZER) Shares?
5 months ago | Simply Wall StWhy Dividend Hunters Love Pfizer Limited (NSE:PFIZER)
Is Pfizer undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: PFIZER (₹5899.45) is trading above our estimate of fair value (₹1994.54)
Significantly Below Fair Value: PFIZER is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: PFIZER is poor value based on its PE Ratio (47.2x) compared to the Indian Pharmaceuticals industry average (27.1x).
PE vs Market: PFIZER is poor value based on its PE Ratio (47.2x) compared to the Indian market (24x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate PFIZER's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: PFIZER is overvalued based on its PB Ratio (11.3x) compared to the IN Pharmaceuticals industry average (3.3x).
How is Pfizer forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Pfizer has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Pfizer performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PFIZER has high quality earnings.
Growing Profit Margin: PFIZER's current net profit margins (23.2%) are lower than last year (24.5%).
Past Earnings Growth Analysis
Earnings Trend: PFIZER's earnings have grown by 15.3% per year over the past 5 years.
Accelerating Growth: PFIZER's earnings growth over the past year (10%) is below its 5-year average (15.3% per year).
Earnings vs Industry: PFIZER earnings growth over the past year (10%) underperformed the Pharmaceuticals industry 53.5%.
Return on Equity
High ROE: PFIZER's Return on Equity (23.9%) is considered high.
How is Pfizer's financial position?
Financial Position Analysis
Short Term Liabilities: PFIZER's short term assets (₹19.2B) exceed its short term liabilities (₹7.7B).
Long Term Liabilities: PFIZER's short term assets (₹19.2B) exceed its long term liabilities (₹985.2M).
Debt to Equity History and Analysis
Debt Level: PFIZER's debt to equity ratio (0.3%) is considered satisfactory.
Reducing Debt: PFIZER's debt to equity ratio has increased from 0.1% to 0.3% over the past 5 years.
Debt Coverage: PFIZER's debt is well covered by operating cash flow (5136.2%).
Interest Coverage: PFIZER earns more interest than it pays, so coverage of interest payments is not a concern.
What is Pfizer current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: PFIZER's dividend (0.59%) is higher than the bottom 25% of dividend payers in the Indian market (0.34%).
High Dividend: PFIZER's dividend (0.59%) is low compared to the top 25% of dividend payers in the Indian market (1.39%).
Stability and Growth of Payments
Stable Dividend: PFIZER's dividend payments have been volatile in the past 10 years.
Growing Dividend: PFIZER's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (23.9%), PFIZER's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Sridhar Subramaniam (53 yo)
Mr. Sridhar Subramaniam has been the Chief Executive Officer, Managing Director and Lead of Essential Health Portfolio of Pfizer Limited since March 18, 2016. He served as Business Unit Head of Pfizer Limi...
CEO Compensation Analysis
Compensation vs Market: Sridhar's total compensation ($USD677.14K) is about average for companies of similar size in the Indian market ($USD643.04K).
Compensation vs Earnings: Sridhar's compensation has increased by more than 20% in the past year.
Experienced Management: PFIZER's management team is seasoned and experienced (8.5 years average tenure).
Experienced Board: PFIZER's board of directors are considered experienced (4.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Pfizer Limited's company bio, employee growth, exchange listings and data sources
- Name: Pfizer Limited
- Ticker: PFIZER
- Exchange: NSEI
- Founded: 1950
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: ₹270.273b
- Shares outstanding: 45.75m
- Website: https://www.pfizerindia.com
Number of Employees
- Pfizer Limited
- The Capital
- 1802 / 1901, 18th Floor
Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including anti-allergic, anti-diabeti...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/08/04 15:37|
|End of Day Share Price||2021/08/04 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.